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Oxidative DNA damage is produced by reactive oxygen species (ROS) which are generated by exogenous and endogenous sources
and continuously challenge the cell. One of the most severe DNA lesions is the double-strand break (DSB), which is mainly
repaired by nonhomologous end joining (NHEJ) pathway in mammals. NHEJ directly joins the broken ends, without using the
homologous template. Ku70/86 heterodimer, also known as Ku, is the ﬁrst component of NHEJ as it directly binds DNA and
recruits other NHEJ factors to promote the repair of the broken ends. Neurons are particularly metabolically active, displaying
high rates of transcription and translation, which are associated with high metabolic and mitochondrial activity as well as oxygen
consumption. In such a way, excessive oxygen radicals can be generated and constantly attack DNA, thereby producing several
lesions. This condition, together with defective DNA repair systems, can lead to a high accumulation of DNA damage resulting in
neurodegenerativeprocessesanddefectsinneurodevelopment.Inlightofrecentﬁndings,inthispaper,wewilldiscussthepossible
implication of Ku in neurodevelopment and in mediating the DNA repair dysfunction observed in certain neurodegenerations.
1. OxidativeDNA Lesions andRepair Systems
Reactive oxygen species (ROS) are constantly produced
inside the cell and mediate diﬀerent oxidative reactions with
various cellular molecules (phospholipids, proteins, RNA,
and DNA) [1]. In particular, ROS are genotoxic and capable
to be harmful to DNA by generating various oxidative DNA
l e s i o n sw i t hb a s eo rs u g a rd a m a g e[ 2]. ROS can be produced
endogenously as side eﬀect of normal cellular metabolism,
in particular by the mitochondrial oxidative metabolism
[3]; or exogenously, by chemical and physical stress (e.g.,
ionizing or ultraviolet radiations) [4, 5]. The modiﬁcations
or alterations inﬂicted on DNA have potentially serious
consequences for the cell. Five main classes of hydroxyl
radical-mediated oxidative damage may be generated: oxi-
dized bases, abasic sites, DNA-DNA intrastrand adducts,
DNA strand breaks (single-strand break, SSB, and double-
strand break, DSB), and DNA-protein cross-links [1, 6].
The low redox potential of guanine renders this base
particularly vulnerable although the number of diﬀerent
lesions is not higher than with other bases. The most
thoroughly examined guanine oxidation product is the 8-
oxo-2 deoxyguanosine (8-OHG), which is both mutagenic
and carcinogenic in that it can pair with either cytosine
or adenine causing GC to AT transversions [7, 8]. The
oxidation of nucleotides in the DNA does not lead to direct
breaks of the DNA. However, when hydroxyl radical attacks
the sugar-phosphate backbone, it can generate SSB. If two
reactions of that type occur in close vicinity (clusters),
a DSB formation is possible [9]. Breaks of both DNA
strands could also occur after conversion of labile lesion
to SSB or after enzymatic processing of base damage [9].
Nevertheless, if left unrepaired, or repaired incorrectly, DNA
lesions may result in massive loss of genetic information,
genomic rearrangements, or cell death. Therefore, the cell
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The four major pathways for repairing damage to DNA
are mismatch repair (MMR), nucleotide excision repair
(NER), base excision repair (BER), and double-strand break
repair (DSBR). DNA mismatch repair (MMR) is a highly
conserved pathway that removes base-base mismatches and
insertion-deletion loops that arise during DNA replication
and recombination [10]. The nucleotide excision repair
(NER) is a complex DNA repair system that recognizes
bulky, helix-distorting lesions, such as pyrimidine dimers
and 6–4 photoproducts, intrastrand crosslinks [11], DNA-
protein cross-links [12] ,a n ds o m eD N Aa d d u c t sc a u s e db y
oxidative damage [13, 14]. NER involves the excision of a
single-stranded lesion-containing oligonucleotide fragment,
thus creating a single-strand gap in the DNA. This gap is
subsequently ﬁlled during repair synthesis by a DNA poly-
meraseusingtheundamagedstrandasatemplate[15].There
is, however, an alternative NER pathway that is coupled
to active transcription and is termed transcription-coupled
repair [16] .B E Ri n v o l v e st h er e m o v a lo fo n en u c l e o t i d e
(short-patch BER, SP-BER) or 2–13 nucleotides (long-patch
BER, LP-BER) by a glycosylase action (i.e., 8-oxoguanine
DNA glycosylase, OGG1), in which the other strand is used
as a template to repair the speciﬁc lesion [17]. In SP-BER, the
DNA polymerase beta (POLB) plays a crucial role carrying
out two distinct and essential enzymatic reactions: it uses
its DNA polymerase activity to ﬁll in the one-nucleotide
g a p ,a n di ta l s ou s e si t s5  -deoxyribophosphatase activity to
cleave the 5  phosphate to allow for eﬃcient ligation (lyase
activity) [18, 19]. SSB can be induced during the repair of 8-
oxoG by BER pathway, or it can occur in the absence of BER
when hydroxyl radical attacks and breaks directly the sugar-
phosphate DNA backbone, without creating a base damage.
Thus, SSBR is always integrated in the BER pathway, but it
can be triggered in the absence of BER [15]. SSBR utilizes, in
fact, many of the same proteins and follows essentially the
same procedure, as BER. SSBR has also two subpathways,
short-patch (SP) and long-patch (LP), similar to BER [20].
When both strands of DNA are damaged, the cell activates
the double-strand break repair (DSBR), which involves one
of two mechanisms: homologous recombination (HR) or
nonhomologousendjoining(NHEJ)[21].Thetwopathways
diﬀer in their ﬁdelity and their template requirements. HR
uses an undamaged DNA template on the sister chromatid
or homologous chromosome to repair the break, leading
to the reconstitution of the original sequence. In fact, HR
is restricted to the late S to G2/M phase of the cell cycle,
whenasisterchromatidisavailableinproliferatingcells[22].
In contrast, NHEJ involves binding of Ku70/86 heterodimer
to the two DNA termini and putting them directly back
together, without the use of a homologous template. In fact,
NHEJisanerror-proneprocess:hence,itisnotabletorestore
the sequence information in the DNA, causing the accumu-
lation of randomly located mutations in the genome of each
somatic cell of an organism [23]. However, NHEJ preserves
the phosphodiester backbone and the molecular integrity
of the chromosome, avoiding the loss of several hundreds
of genes on entire chromosomal arms or segments [24].
Nevertheless, NHEJ is evolutionarily conserved throughout
the animal kingdom and is the predominant double-strand
break repair pathway in mammalian cells [25], because it
functions either throughout the cell cycle or in postmitotic
diﬀerentiated cells [15, 22], and because it does not require
the sequence of a sister chromatid.
2. NHEJ in the Nervous System
Sincethematurenervoussystemislargelypostmitotic,NHEJ
is the main DNA DSB repair pathway in the brain [15, 26].
In fact, several observations in the mouse knockout models
of NHEJ factors, reviewed in [27], and diﬀerent analyses
of NHEJ activity in mature rat brain [26, 28, 29] point
towards the importance of NHEJ in neuronal function and
homeostasis. Neurons are particular in being terminally
diﬀerentiated, postmitotic cells, while also being extremely
metabolically active. They, in fact, display high rates of
transcription and translation, which are associated with high
metabolic rate and mitochondrial activity, and thus with a
high rate of oxygen consumption. The nervous system is also
very rich in polyunsaturated fatty acids (PUFAs) and has a
high content of transition metals and ascorbate levels, which
together act as potent oxygen radical-generating system. On
the other hand, it possesses a relative paucity of antioxidant
systems compared with other organs, so that the nervous
systemishighlyvulnerabletooxidativestress.Excessivelevels
of ROS can be therefore generated and constantly attack
DNA producing several lesions [30–32]. Among them, DSB,
although being less frequent, is one of the most toxic and
mutagenic lesions [9]. Furthermore, defective DNA repair
systems in neurons can lead to a high accumulation of
DNA damage, such as chromosomal breaks. In particular,
during neural development, defects in NHEJ can result in
neuropathology (i.e., neurodegeneration and microcephaly),
suggesting that responding to DNA DSBs is essential for
neural homeostasis [33–35].
Development of the nervous system occurs in a basic
pattern of proliferation, diﬀerentiation, migration, and mat-
uration. The nervous system generates from proliferative
ventricular zones that form neural precursor cells. Two main
classes of cells make up the nervous system, neurons, and
glia, these also encompassing many specialized subtypes. As
these cells exit the cell cycle, they migrate and diﬀerentiate,
establishing the nervous system’s shape. Moreover, the
development of nervous system is characterized by a massive
apoptosis from the early stages of proliferation until the
later stages of functional maturation, constituting a part of
the process that generates the system’s sophisticated cytoar-
chitecture and connectivity. Inactivation of critical proteins
involved in NHEJ pathway has been demonstrated to have
detrimental eﬀects in neurodevelopment [36–40]. The DNA
ligase IV-deﬁcient mouse shows massive cell death in the
developing nervous system and embryonic lethality [36].
Thisdramaticapoptosismaybeareﬂectionofthepropensity
of damaged neuronal cells to undergo apoptosis rather
than to mature into diﬀerentiated neurons. Individuals with
mutations in LIG4 exhibit immunodeﬁciency, developmen-
taldelay,growthretardation,andmicrocephaly,adiseasethat
hasbeentermedLIG4syndrome[40].Thefactthatknockout
mice lacking functional Lig4 are not viable [36] indicatesInternational Journal of Cell Biology 3
that the mutations in the LIG4 syndrome patients might be
hypomorphic alleles. However, considering the high level of
apoptosis detected in Lig4-deﬁcient mice, it is possible that
LIG4 syndrome patients also experience elevated neuronal
apoptosis during development, this possibly underlying the
reported microcephaly and developmental delay [36, 40].
Furthermore, in mature brain, the inability to respond
to DNA DSBs may lead to neurodegenerative disorders. In
particular, it has been reported that genes involved in sig-
naling pathway which coordinates cell cycle arrest after DNA
DSB, such as the ataxia telangiectasia mutated gene (ATM),
are associated, when defective, with neurodegenerative dis-
orders (ataxia-telangiectasia and ataxia-telangiectasia-linked
disorder, AT and ATLD) [15]. ATM is a protein kinase
whose DNA damage-induced phosphorylation of various
substrates is involved in cell cycle regulation or maintenance
of genomic stability [41–43]. Moreover, the high oxidative
DNA damage and the decreased DNA repair observed in
Alzheimer’s patients [44, 45] have been correlated to defects
in the NHEJ repair process, although a precise locus or
gene(s) aﬀe c t e di nt h i sp a t h w a yh a sn o ty e tb e e ni d e n t i ﬁ e d
[46].
2.1. Multiple Functions of Ku. Like most DNA repair pro-
cesses, the NHEJ pathway of DSBs requires three enzymatic
activities: (i) nucleases to remove damaged DNA, (ii)
polymerases to aid in the repair, and (iii) a ligase to restore
the phosphodiester backbone [25]. However, the ﬁrst step
is the recognition of the lesion. Ku is, indeed, deputed to
this function. Ku is a heterodimer formed of two subunits:
Ku70 and Ku86 (also termed Ku80) [47]. In particular, the
complex binds directly the two broken DNA termini so
protecting them from excessive degradation and ultimately
preparing them for ligation [24]. As shown in Figure 1, the
Ku heterodimer is capable of interacting with the nuclease
(Artemis-DNA-PKcs) complex, the polymerases (pol μ and
pol λ), and the ligase (XLF-XRCC4-DNA Lig IV) complex.
Ku ﬁrst recruits the catalytic subunit of the DNA-PK (DNA-
PKcs) and Artemis, this preventing the premature processing
of DNA ends, in the repair site [24]. It likely changes confor-
mation once it slides onto the DNA end, since Ku complexes
with DNA-PKcs are not detected except when Ku is bound to
aDN Aend[48].Thenew-formedcomplex(DNA-PK)isable
tophosphorylateitself,Artemis,anddiﬀerentsubstrates.The
autophosphorylation causes a conformational change, and
DNA-PKcs dissociate from DNA allowing the recruitment
of several end-processing enzymes, including XRCC4, DNA
Lig IV, and Cernunnos/XLF [23]. The consequence of these
activities is the rejoining of DNA ends and the repair of
DNA damage. DSBs can also induce the phosphorylation of
histone H2AX in the vicinity of DSBs by members of the
phosphatidylinositol-3 kinase (PI3K) family, such as DNA-
PKcs, ATM, and ATR. This is considered a crucial signal
for the cell in order to activate the DNA repair response,
since it serves as a site for the accumulation and retention
of the central components of the signaling cascade initiated
by DNA damage [49].
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Figure 1: ROS can generate double-strand breaks with heteroge-
neous incompatible DNA ends. Following DSB formation, Ku70
and Ku86 form the heterodimer Ku, which can bind directly the
two broken DNA termini. Ku, likely changing conformation once
it slides onto the DNA end, recruits DNA-PKcs and Artemis to
form the DNA-PK complex, which brings the two DNA ends close
together and protects them from excessive degradation. DNA-PK
phosphorylates itself and also mediates a regulatory phosphoryla-
tion of other NHEJ components, such as Artemis. Subsequently, the
DNA polymerases (including the pol X polymerases, pol μ and λ)
synthetize each DNA segment necessary for the repair. Finally, the
DNA-PK complex recruits the LIG4-XRCC4-XLF complex in order
to perform the ligation of the DNA termini, after which the DNA-
repair factors dissociate.
The Ku complex was originally found as a major target of
autoantibodies taken from Japanese patients with scleroma-
polymyositis overlap syndrome [50, 51]. Current knowledge
on Ku deals with its fundamental role in DNA repair. That
said, the Ku complex is also implicated in other cellular
processes, including telomere maintenance, antigen receptor
gene arrangements (VDJ recombination), regulation of
speciﬁc gene transcription and apoptosis [47]. For instance,4 International Journal of Cell Biology
Ku has been found to protect telomeres from inappropriate
degradation and interchromosomal recombination; to con-
tributeto the tethering oftelomeres to the nuclearperiphery;
to regulate telomerase [52]. Wang and coworkers (2009)
have also demonstrated that Ku plays an essential role in
human cells, because it prevents dramatic telomere loss. In
particular, they showed that the cell death that resulted from
the conditional knockout of Ku86 in a human somatic cell
line was associated with massive telomere loss [53].
Variable (V), diversity (D), and joining (J) gene-segment
recombination is initiated by the generation of sequence-
speciﬁc DSBs by an enzyme complex (which consists of the
recombination-activating gene (RAG)1 and RAG2 proteins)
at the ends of two coding segments that have to be joined.
The subsequent processing and repair of the resulting
structures is performed by NHEJ; therefore, Ku is involved
in this process [54]. This kind of DSBs is not pathologic but
functions so as to rearrange the genome to generate diversity
in the immune system. Moreover, Ku70 can be involved
in the regulation of mitochondrial apoptotic pathway by
sequestering Bax from the mitochondria, in an acetylation-
sensitive manner, and by mediating Bax deubiquitylation
[55, 56]. In particular, it has been demonstrated that,
under normal growth conditions, Ku70 is maintained in a
nonacetylated state by the histone deacetylases (HDACs),
such as the NAD+-dependent SIRT1, which enables its
associationwithBax.Afterapoptoticstimuli,theacetyltrans-
ferases CBP and PCAF acetylate speciﬁc lysines on Ku70,
resulting in a conformational change of Ku70 and the Bax
release, that can act, in such a way, to initiate apoptosis [57].
Sawada and coworkers (2003) characterised for the ﬁrst time
the interaction between Bax and Ku70, identifying the Bax-
binding domain of Ku70 within amino acids 578–583 [58].
They also found out that the cell permeable pentapeptide
designed from the Bax-inhibiting domain of Ku70 is able to
inhibit Bax-induced cell death [59]. These extensive studies
were published in 2003 but retracted in 2007. However,
several works dealing with Bax-Ku70 interaction, as well as
withthecytoprotectiveeﬀectofBax-inhibitingpentapeptide,
collectively conﬁrmed the reproducibility of the former
ﬁndings [55–57, 60–62]. Indeed, Bax-inhibiting peptides
were abundantly used in a number of works, which point
out the relevance of Bax-Ku70 interaction in apoptosis
induction, that is, in the susceptibility of cell death of human
laminin-alpha2-deﬁcient myotubes and mouse models of
congenitalmusculardystrophy[60];intheprotectionofcells
frompolyglutaminetoxicitycausedbyKu70acetylation[61];
or in the reduction of neuronal death and behavioral deﬁcits
following global cerebral ischemia [62].
Regarding its transcriptional function, the Ku complex
has been reported to act in both a sequence-nonspeciﬁc
and -speciﬁc manner. This factor has been found to be
associated with RNA polymerase II elongation sites, without
a sequence-speciﬁc DNA binding [63]. Ku can interact with
the sugar bonds of DNA through the central ring of the
protein formed by the two subunits Ku70 and Ku86, in
a sequence nonspeciﬁc manner, which is already known
being the way to bind DSBs [47]. On the other hand,
there are several reports indicating that the Ku complex is
a transcription modulator. In particular, it has been reported
(i) to repress human α-myosin heavy-chain promoter during
heart failure [64]; (ii) to contribute to ERBB2 oncogene
overexpression in breast cancer cells by the interaction
with activator protein-2 [65]; (iii) to regulate S100A9 gene
expression, which is a member of a multigenic family of
nonubiquitouscytoplasmicCa2+-bindingproteins,alongside
poly(ADP-ribose)polymerase-1 [66]; to act as corepressor
in farnesoid X receptor-mediated gene expression [67];
(iv) to function as transcriptional recycling coactivator of
the androgen receptor [68]. In addition, we have recently
reported that Ku is involved in the repression of the
proapoptotic gene Apaf1 upon DNA damage [69]. Actually,
we still do not know which is the Ku70 and/or Ku86
domain(s) implicated in the speciﬁc interaction with DNA
and how it occurs. However, we can speculate that the C-
terminus domain of Ku70, called SAP (SAF-A/B, Acinus, and
PIAS) [70], which is found in proteins involved in chromatin
remodelling [71, 72], could have a role in this process. We
cannot exclude that Ku-related transcription function is the
result of the interaction with other still characterised factors,
which speciﬁcally bind promoter elements, at least in those
cases where Ku is reported acting as a cofactor [64–68]. In
this scenario, Ku could represent a chromatin-remodelling
factor conferring to chromatin an open/close structure, even
though being still capable to bind the DNA in a sequence-
nonspeciﬁc manner.
3. Ku Involvement in Neuronal Homeostasis
Ku is involved in the signalling pathway which follows the
DNA DSB repair. As above mentioned, it can regulate the
mitochondrial pathway of apoptosis either by negatively
modulating the expression of the proapoptotic gene Apaf1
[69] or by interacting with Bax [55–59], with both these
functions mostly observed in cells of neuronal origin.
Accordingly,wehavedemonstratedtheKumediatesdynamic
modulation of Apaf1 in neural progenitors deriving from the
telencephalon of embryonic stage 14 mice [69]. Moreover,
a large body of evidence obtained in neuroblastoma cells
[55, 73], primary cortical neurons [61], retinal ganglion cells
[74], and in mouse brain [62] argues for Ku70 negatively
aﬀecting the proapoptotic activity of Bax. In such a way,
Ku would exert a double prosurvival role within the cell, by
participating in the DNA repair response and by preventing
the mitochondrial apoptotic pathway.
The dysfunction of Ku has been demonstrated to have
detrimental eﬀects in the nervous system where the NHEJ
pathway is the fundamental DSBs repair system used by
neurons and where the apoptotic cell death can regulate neu-
ral development (Figure 2). For instance, the lack of either
Ku70 and/or Ku86 in knockout mice results in dramatic
apoptosis of many types of developing embryonic neurons
ofspinalcord,cerebralcortex,midbrain,andhindbrain[75].
ApoptosishasalsobeenfoundintheembryonicretinainKu-
null animals [76]. Notably, the neuronal apoptosis observed
in the Ku70 and Ku86 knockouts is not as severe as in knock-
outs of the other NHEJ components, and, in fact, the Ku70International Journal of Cell Biology 5
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Figure 2: Ku dysfunction can lead to pathological states of the nervous system. Besides NHEJ impairment, which results in DNA damage
accumulation, Ku-related alterations of the mitochondrial apoptotic pathway can play a crucial role in neurodevelopment disorders and
neoplastic transformations. In particular, Bax-Ku70 and/or Apaf1 promoter-Ku interaction can be decreased and lead to massive apoptosis
upon Ku loss of function, as observable in Ku-related disorders of neurodevelopment. Alternatively, Ku gain of function in tumors of the
nervous system may lead to an increase of Ku binding to Bax and/or the Apaf1 promoter, thus leading to evade apoptosis and to increase
chemoresistance. On the other hand, in a mature nervous system, Ku sequestration mediated by mutant huntingtin can contribute to the
HD pathology, by leading to an altered DSBs repair by NHEJ.
and Ku80 knockouts survive into adulthood, even though
no apoptosis was found in the nervous system of DNA-
PKCS-null mice [75]. It has been suggested that neuronal
cells might be particularly prone to apoptosis in response
to DSBs during neurodevelopment, perhaps in order to
eliminate damaged neurons and guarantee a suﬃcient cell
replacement for maintaining neural development [77]. In
Ku70−/− mice, migrating cortical neurons, which normally
undergo oxidative DNA damage, fail to repair DNA lesion
by NHEJ and undergo apoptosis [78]. In addition, it has
been demonstrated that the DNA-PK complex, including
Ku, can promote survival of young neurons in embryonic
mouse retina, thus conﬁrming the critical role of Ku in
regulating neurogenesis [79]. In this regard, it has to be
also considered that the Ku70/Bax interaction is probably
abolished in a Ku-depleted background. This interaction is
crucial in regulating the mitochondrial apoptotic pathway by
preventing Bax localization into the mitochondria [55–62],
and its absence could contribute to the massive apoptosis
observed in nervous system of Ku knockout mice. Also,
the speciﬁc Ku-mediated modulation of the apoptotic gene
Apaf1 observed in neural progenitors could account for the
excessive cell death observed in Ku-depleted backgrounds
[69].Alltheabove-mentionedprocessesargueforKuplaying
a critical role in neuron survival, either by participating
in DSB repair through NHEJ or by regulating apoptosis.
According to these assumptions, Ku could also have a role in
the chemoresistance of tumors originating from the nervous
system(Figure2).Aspartoftheirmechanismofaction,most
chemotherapeutics aﬀect DNA integrity through the gener-
ation of diﬀerent lesions, such as DSBs. Indeed, it has been
reported a correlation between resistance to chemo- and/or
radiotherapy and a high Ku70–Ku86 expression/activity [80–
82] Moreover, some reports have shown the modulation of
Ku70 acetylation status and Ku70-Bax interaction, by means
of HDAC inhibitors, both eﬀects inducing chemosensitivity
in medulloblastoma and neuroblastoma cells [55, 73, 83]. All
this conﬁrms a pivotal role for Ku in neuronal homeostasis
and survival.
Enokido and coworkers (2010) have also demonstrated
a critical involvement of Ku70 in the pathogenesis of the
Huntington’s disease (HD) [84]. In particular, they found
that mutant huntingtin speciﬁcally interacts with Ku70,
resulting in Ku70 sequestration and its inability to function
in the NHEJ pathway. This leads to the impairment of the
DNA repair process by NHEJ and to the accumulation of the
DNA damage in neurons (Figure 2). In fact, DNA damage
repair has been recently shown to be a critical component of
several polyglutamine (polyQ) disease pathologies, such as
HD [85]. Also, it has been demonstrated that accumulated
oxidative DNA damage triggers activation of the single-base
excision repair enzyme oxoguanine glycosylase 1 (OGG1),
thereby enhancing the CAG repeat instability during aging
in somatic cells of polyQ patients [85]. The work of Enokido
and collegues (2010) deﬁnitely demonstrates that Ku70
is the mediator of the DNA repair dysfunction. In their
experimental conditions, a speciﬁc Ku70 sequestration by
the mutant huntingtin prevented an eﬃcient DNA damage6 International Journal of Cell Biology
repair by the NHEJ pathway. They also showed that Ku70
supplementation rescues phenotypes of HD mouse model
[84]. More recently, it has been demonstrated that, in
DrosophilamodelsofHD,huntingtinandKu70coexpression
recovers lifespan, locomotive activity, and eye degeneration,
thus supporting the hypothesis that Ku70 is a critical and
conserved mediator of the HD pathology [86].
4. Conclusions
As discussed above, a critical process for maintaining
homeostasis in the brain is an eﬀective response to oxidative
DNA damage. One of the most serious DNA lesions is DSB,
and the NHEJ is the predominant pathway used by the
cells to repair this kind of damage. Among NHEJ proteins,
Ku is a key factor in regulating the cellular response to
DSBs, since it directly promotes DNA repair by binding
the broken ends, and participating in the modulation of
critical apoptotic proteins, such as Bax and Apaf1. The
genetic manipulation of Ku in mice has shown how it can
be fundamental for brain development and homeostasis.
However, the regulation of NHEJ and the mitochondrial
apoptotic pathway could also represent two independent
functions that Ku exerts in neurons. This could explain
some important inconsistencies, such as the fact that the sole
absence of LigIV or XRCC4 is suﬃcient to lead a massive
apoptosisandalethalphenotypeinknock-outmiceforthese
genes, still having a functionally active Ku. In fact, Ku could
bind and repress the Apaf1 gene far more in diﬀerentiated
postmitoticneuronsthaninneuralprogenitors,asourrecent
ﬁndings in neuronal precursor cells bear out [69]. In fact,
Apaf1 has to be expressed at high levels in these cells, in
order to guarantee the potential of displaying apoptosis. On
the other hand, mature neurons have to avoid cell death,
survivingaslongastheorganismdoes.Forthisreason,Apaf1
silencing mediated by Ku could be a strategy which neurons
adopt to escape apoptosis, thereby highlighting the pivotal
function of Ku as a key regulator of neuron survival.
Finally, the discovery that exogenous Ku70 expression
rescues abnormal behavior and pathological phenotypes in a
mouse model of HD [84, 86], where DNA repair is impaired,
provides the ﬁnal evidence that Ku plays a crucial role in
regulating brain homeostasis. Thus, Ku could be a promising
therapeutic target in this pathology.
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